Loading clinical trials...
Loading clinical trials...
To evaluate the survival benefit associated with Zemplar therapy as compared to Calcijex for the treatment of secondary hyperparathyroidism in subjects with Stage V chronic kidney disease on hemodialy...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Abbott
NCT06660277 · Chronic Kidney Disease Requiring Hemodialysis, End-Stage Kidney Disease (ESKD), and more
NCT06700876 · Tuberculosis (TB), End-Stage Kidney Disease
NCT06842927 · End-Stage Kidney Disease, End Stage Renal Disease (ESRD), and more
NCT06693765 · Renal Impairment, End-stage Kidney Disease, and more
NCT05656040 · End-Stage Renal Disease, End-Stage Kidney Disease, and more
Tuscaloosa Nephrology Associates
Tuscaloosa, Alabama
Gambro Healthcare - Inglewood
Inglewood, California
Gambro Healthcare - Los Angeles
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions